LUND, Sweden, 31 May 2018 /PRNewswire/ --NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP) (OTCQX: NEVPF), the mitochondrial medicine company, today announced an increase of the number of shares and votes in NeuroVive of 39,244,644 as a result of a preferential rights issue in NeuroVive...
from PR Newswire: //https://ift.tt/2JjI2ag
No comments:
Post a Comment